Annual report pursuant to Section 13 and 15(d)

Note 4 - Acquisitions - Preliminary and Final Fair Value of Assets and Liabilities Assumed (Details)

Note 4 - Acquisitions - Preliminary and Final Fair Value of Assets and Liabilities Assumed (Details) - USD ($) $ in Thousands						8 Months Ended	12 Months Ended
	Apr. 06, 2021	Oct. 20, 2020	Jun. 04, 2019	Aug. 01, 2018	Jul. 02, 2018	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Goodwill						$ 843,067	$ 843,067	$ 728,308	$ 732,667
Payments to Acquire Businesses, Net of Cash Acquired, Total							225,352	(0)	$ 289,492
Changzhou Eminence Biotechnology [Member]
Current assets, net of cash		$ 3,145				3,145	3,145
Equipment and other long-term assets		1,639				1,639	1,639
Goodwill		8,811				7,848	7,848
Goodwill, Purchase Accounting Adjustments						(963)
Total assets acquired		22,506				21,543	21,543
Total assets acquired, adjustments						(963)
Liabilities		1,436				1,436	1,436
Deferred income taxes, net		2,320				1,357	1,357
Deferred income taxes, net, adjustments						(963)
Net assets acquired		18,750				18,750	18,750
Payments to Acquire Businesses, Net of Cash Acquired, Total		9,765				9,765
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value		8,985				8,985	8,985
Net assets acquired		18,750				18,750
Net assets acquired		9,800
Changzhou Eminence Biotechnology [Member] \| Developed Technology Rights [Member]
Intangible assets		6,778				6,778	6,778
Changzhou Eminence Biotechnology [Member] \| Customer Relationships [Member]
Intangible assets		$ 2,133				$ 2,133	$ 2,133
Acquisition of Asuragen, Inc. [Member]
Current assets, net of cash	$ 10,422
Equipment and other long-term assets	3,762
Goodwill	94,970
Total assets acquired	253,554
Liabilities	4,003
Deferred income taxes, net	15,664
Net assets acquired	233,887
Payments to Acquire Businesses, Net of Cash Acquired, Total	215,587
Contingent consideration payable	18,300
Net assets acquired	233,887
Acquisition of Asuragen, Inc. [Member] \| In Process Research and Development [Member]
In-process research and development	22,700
Acquisition of Asuragen, Inc. [Member] \| Developed Technology Rights [Member]
Intangible assets	107,000
Acquisition of Asuragen, Inc. [Member] \| Customer Relationships [Member]
Intangible assets	11,700
Acquisition of Asuragen, Inc. [Member] \| Trade Names [Member]
Intangible assets	2,000
Acquisition of Asuragen, Inc. [Member] \| Noncompete Agreements [Member]
Intangible assets	$ 1,000
B-MoGen [Member]
Current assets, net of cash								504
Equipment and other long-term assets								269
Goodwill								16,131
Goodwill, Purchase Accounting Adjustments								300
Total assets acquired								31,304
Liabilities								211
Deferred income taxes, net								3,051
Net assets acquired								28,042
Payments to Acquire Businesses, Net of Cash Acquired, Total			$ 17,500					17,448
Net assets acquired								28,042
Contingent consideration payable								10,594
B-MoGen [Member] \| Developed Technology Rights [Member]
Intangible assets								14,000
B-MoGen [Member] \| Customer Relationships [Member]
Intangible assets								400
Exosome Diagnostics, Inc [Member]
Current assets, net of cash								2,611
Equipment and other long-term assets								2,212
Goodwill								105,362
Total assets acquired								275,485
Liabilities								3,716
Deferred income taxes, net								16,346
Net assets acquired								255,423
Payments to Acquire Businesses, Net of Cash Acquired, Total				$ 251,600				251,623
Net assets acquired								255,423
Contingent consideration payable								3,800
Exosome Diagnostics, Inc [Member] \| Developed Technology Rights [Member]
Intangible assets								105,000
Exosome Diagnostics, Inc [Member] \| Customer Relationships [Member]
Intangible assets								2,300
Exosome Diagnostics, Inc [Member] \| Trade Names [Member]
Intangible assets								58,000
QT Holdings Corporation [Member]
Current assets, net of cash								36
Equipment and other long-term assets								228
Goodwill								14,481
Total assets acquired								27,001
Liabilities								296
Deferred income taxes, net								943
Net assets acquired								25,762
Payments to Acquire Businesses, Net of Cash Acquired, Total					$ 20,500			20,462
Net assets acquired								25,762
Contingent consideration payable								5,300
QT Holdings Corporation [Member] \| Developed Technology Rights [Member]
Intangible assets								$ 12,256